Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: A case-control study within the UKCTOCS cohort

The Lancet Oncology

Volumn 12, Issue 1, 2011, Pages 38-48

  Jacobs, Ian ^a   Gentry Maharaj, Aleksandra ^a   Burnell, Matthew ^a   Manchanda, Ranjit ^a   Singh, Naveena ^b   Sharma, Aarti ^c   Ryan, Andy ^a   Seif, Mourad W ^d   Amso, Nazar N ^e   Turner, Gillian ^f   Brunell, Carol ^g   Fletcher, Gwendolen ^a   Rangar, Rani ^h   Ford, Kathy ⁱ   Godfrey, Keith ^h   Lopes, Alberto ^j   Oram, David ^k   Herod, Jonathan ⁱ   Williamson, Karin ^c   Scott, Ian ^f   Jenkins, Howard ^f   Mould, Tim ^l   Woolas, Robert ^m   Murdoch, John ⁿ   Dobbs, Stephen ^o   Leeson, Simon ^p   Cruickshank, Derek ^q   Skates, Steven J ^r   Fallowfield, Lesley ^s   Parmar, Mahesh ^t   Campbell, Stuart ^u   Menon, Usha ^a   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b BARTS HEALTH NHS TRUST   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^d ST MARY S HOSPITAL   (United Kingdom)

^e CARDIFF UNIVERSITY   (United Kingdom)

^f DERBY CITY GENERAL HOSPITAL   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^h QUEEN ELIZABETH HOSPITAL   (United Kingdom)

ⁱ LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

^j ROYAL CORNWALL HOSPITALS NHS TRUST   (United Kingdom)

^k ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^l ROYAL FREE HOSPITAL   (United Kingdom)

^m ST MARY S HOSPITAL   (United Kingdom)

ⁿ ST MICHAEL'S HOSPITAL   (United Kingdom)

^o BELFAST CITY HOSPITAL   (United Kingdom)

^p Llandudno LL30 1LB   (United Kingdom)

^q JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^r HARVARD MEDICAL SCHOOL   (United States)

^s UNIVERSITY OF SUSSEX   (United Kingdom)

^t MEDICAL RESEARCH COUNCIL   (United Kingdom)

^u Create Health Clinic   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENDOMETRIUM; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; REFERENCE VALUE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TRANSVAGINAL ECHOGRAPHY; UNITED KINGDOM;

AGED; CASE-CONTROL STUDIES; COHORT STUDIES; EARLY DETECTION OF CANCER; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; SENSITIVITY AND SPECIFICITY; VAGINA;

EID: 78650687714     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(10)70268-0     Document Type: Article

References (41)

1. Bray F, Dos Santos Silva I, Moller H, Weiderpass E Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention. Cancer Epidemiol Biomarkers Prev 2005, 14:1132-1142.
2. Uterus (womb) cancer-UK incidence statistics Cancer research UK, (accessed Oct 5, 2009). http://info.cancerresearchuk.org/cancerstats/types/uterus/incidence/.
3. Haslam DW, James WP Obesity. Lancet 2005, 366:1197-1209.
4. Bray F, Dos Santos Silva I, Moller H, Weiderpass E Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention. Cancer Epidemiol Biomarkers Prev 2005, 14:1132-1142.
5. Aarnio M, Sankila R, Pukkala E, et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999, 81:214-218.
6. Lynch HT, Lynch JF Lynch syndrome: history and current status. Dis Markers 2004, 20:181-198.
7. Smith RA, Cokkinides V, Brawley OW Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 2009, 59:27-41.
8. Smith RA, Cokkinides V, Eyre HJ American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin 2006, 56:11-25.
9. Christensen K, Doblhammer G, Rau R, Vaupel JW Ageing populations: the challenges ahead. Lancet 2009, 374:1196-1208.
10. Uterus (womb) cancer survival statistics Cancer research UK, (accessed Oct 5, 2009). http://info.cancerresearchuk.org/cancerstats/types/uterus/survival/.
11. Buys SS, Partridge E, Greene MH, et al. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol 2005, 193:1630-1639.
12. Menon U, Gentry-Maharaj A, Hallett R, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol 2009, 10:327-340.
13. Fleischer AC, Wheeler JE, Lindsay I, et al. An assessment of the value of ultrasonographic screening for endometrial disease in postmenopausal women without symptoms. Am J Obstet Gynecol 2001, 184:70-75.
14. Karlsson B, Granberg S, Wikland M, et al. Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding-a Nordic multicenter study. Am J Obstet Gynecol 1995, 172:1488-1494.
15. Gull B, Karlsson B, Milsom I, Granberg S Can ultrasound replace dilation and curettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer. Am J Obstet Gynecol 2003, 188:401-408.
16. Tsuda H, Nakamura H, Inoue T, Kawamura N, Adachi K, Bandera CA Transvaginal ultrasonography of the endometrium in postmenopausal Japanese women. Gynecol Obstet Invest 2005, 60:218-223.
17. Menon U, Gentry-Maharaj A, Ryan A, et al. Recruitment to multicentre trials-lessons from UKCTOCS: descriptive study. BMJ 2008, 337:a2079.
18. Trimble CL, Kauderer J, Zaino R, et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer 2006, 106:812-819.
19. Zaino RJ, Kauderer J, Trimble CL, et al. Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer 2006, 106:804-811.
20. Zaino RJ Endometrial hyperplasia: is it time for a quantum leap to a new classification?. Int J Gynecol Pathol 2000, 19:314-321.
21. Kurman RJ, Kaminski PF, Norris HJ The behavior of endometrial hyperplasia. A long-term study of " untreated" hyperplasia in 170 patients. Cancer 1985, 56:403-412.
22. Ferenczy A, Gelfand M The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia. Am J Obstet Gynecol 1989, 160:126-131.
23. Sherman AI, Brown S The precursors of endometrial carcinoma. Am J Obstet Gynecol 1979, 135:947-956.
24. Wentz WB Progestin therapy in endometrial hyperplasia. Gynecol Oncol 1974, 2:362-367.
25. Lacey JV Jr, Sherman ME, Rush BB, et al. Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia. J Clin Oncol 28: 788-92.
26. Eitan R, Saenz CC, Venkatraman ES, et al. Pilot study prospectively evaluating the use of the measurement of preoperative sonographic endometrial thickness in postmenopausal patients with endometrial cancer. Menopause 2005, 12:27-30.
27. Smith-Bindman R, Weiss E, Feldstein V How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding. Ultrasound Obstet Gynecol 2004, 24:558-565.
28. Sit AS, Modugno F, Hill LM, Martin J, Weissfeld JL Transvaginal ultrasound measurement of endometrial thickness as a biomarker for estrogen exposure. Cancer Epidemiol Biomarkers Prev 2004, 13:1459-1465.
29. Ozsener S, Ozaran A, Itil I, Dikmen Y Endometrial pathology of 104 postmenopausal breast cancer patients treated with tamoxifen. Eur J Gynaecol Oncol 1998, 19:580-583.
30. Kedar RP, Bourne TH, Powles TJ, et al. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 1994, 343:1318-1321.
31. Love CD, Muir BB, Scrimgeour JB, Leonard RC, Dillon P, Dixon JM Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening. J Clin Oncol 1999, 17:2050-2054.
32. Bertelli G, Venturini M, Del Mastro L, et al. Tamoxifen and the endometrium: findings of pelvic ultrasound examination and endometrial biopsy in asymptomatic breast cancer patients. Breast Cancer Res Treat 1998, 47:41-46.
33. Cecchini S, Ciatto S, Bonardi R, et al. Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen. Gynecol Oncol 1996, 60:409-411.
34. Gerber B, Krause A, Muller H, et al. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound. J Clin Oncol 2000, 18:3464-3470.
35. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 2005, 97:1652-1662.
36. Sherman ME, Lacey JV, Buys SS, et al. Ovarian volume: determinants and associations with cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev 2006, 15:1550-1554.
37. Epstein E, Valentin L Intraobserver and interobserver reproducibility of ultrasound measurements of endometrial thickness in postmenopausal women. Ultrasound Obstet Gynecol 2002, 20:486-491.
38. Viswanathan AN, Feskanich D, De Vivo I, et al. Smoking and the risk of endometrial cancer: results from the Nurses' Health Study. Int J Cancer 2005, 114:996-1001.
39. Weiderpass E, Persson I, Adami HO, Magnusson C, Lindgren A, Baron JA Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 2000, 11:185-192.
40. Jonsson F, Wolk A, Pedersen NL, et al. Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry. Int J Cancer 2003, 106:594-599.
41. Bell R, Petticrew M, Sheldon T The performance of screening tests for ovarian cancer: results of a systematic review. Br J Obstet Gynaecol 1998, 105:1136-1147.